CleveMed Blogs

CLEVELAND, OHIO, May 22, 2009 – Cleveland Medical Devices Inc. (CleveMed) announced that it has registered its sleep diagnostic devices in Colombia, Taiwan, Singapore, Malaysia and the Philippines, opening the door to product distribution in these countries.

CleveMed’s Division of Sleep Disorders offers complete wireless PSG systems, such as the 14-channel Crystal Monitor® PSG Series and the 22-channel Sapphire PSG™. The SleepScout™ is a type III monitor for home sleep testing. All four systems include Crystal PSG™ software, a user-friendly software package for data acquisition, scoring and reporting that are used by clinicians in the diagnosis of sleep disorders. (View Overview Video) The Crystal Monitor 20-S, Crystal Monitor 20-B and Sapphire PSG systems can all be upgraded with the iPSG Inpatient PSG System to allow for remotely attended sleep studies in hospital rooms. Due to the systems’ compact size, wireless design, fast and simple system setup and rearrangement, they are uniquely suited not just for studies in the traditional sleep lab setting, but also for nontraditional sleep applications such as hospital inpatient testing for pre-surgical evaluation, nursing homes, “hotel sleep labs” and patients’ homes.

“This is a significant milestone in CleveMed’s pursuit for global expansion. We are very excited about establishing distributorships in these areas. CleveMed is also working toward medical device CE Marking to be able to distribute its products in Europe as well”, says Del Basa, International Sales Manager at CleveMed.

About Sleep Apnea

Sleep apnea is a serious chronic sleep disorder where patients stop breathing numerous times during the night, which fragments their sleep and stresses the cardiopulmonary system during what is meant to be a restful and regenerative period. Read more about Sleep Apnea here.

About CleveMed

CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders and sleep disorders. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.clevemed.com

For More Information Contact:

Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
www.clevemed.com

This won’t quite be a 140-character-tweet, but I will make an attempt at brevity in honor of Twitter. In case you didn’t already know, CleveMed is on Twitter and a-tweetin’! Follow CleveMed on Twitter (http://twitter.com/CleveMed) and see updates on our products, services, conferences & tradeshows, links to news articles, etc.

But you’ll also see tweets like this one:

Or this:

Moral of my story:
Follow CleveMed on Twitter. You’ll also find us on other online communities like Facebook (CleveMed Movement), Facebook (CleveMed Sleep), LinkedIn and YouTube. PS: Here’s a link to “All You Need to Know to Twitter” from the NY Times.

The American Medical Association CPT (Current Procedural Terminology) Editorial Panel has approved the release of CPT^® code 0199T: Physiologic recording of tremor using accelerometer(s) and gyroscope(s), (including frequency and amplitude) including interpretation and report. Implementation date is July 1, 2009.

CleveMed has worked diligently with key personnel as well as members of the American Medical Association on the implementation of the 0199T Category III code to cover Kinesia^TM, a wireless patient worn device for objectively monitoring the severity of movement disorder motor symptoms.

Currently, Kinesia is the only device on the market that uses accelerometers AND gyroscopes, as defined in the description of the code, for the physiologic recording of tremor.

Kinesia is a compact device worn on the hand and wrist of the patient while they complete a video-guided upper extremity motor symptom evaluation. Symptom severity information is wirelessly telemetered to a nearby computer, increasing patient mobility and simplifying setup, where it is displayed and stored. Tasks for evaluating tremor, including rest, postural and kinetic, are automatically scored on a 0 to 4 scale. Severity scores can be viewed in customizable patient reports.

If you have questions regarding Category III codes, reimbursement or other information, please contact a CleveMed representative at 1-877-253-8363 or visit our website at www.CleveMed.com.